Highlights of the important and interesting in the world of healthcare:
FDA’s Avandia call… correct? What does Cleveland Clinic cardiologist (and Avandia whistleblower) Steven Nissen have to say about Thursday’s Food and Drug Administration decision to allow diabetes drug Avandia to stay on the market with significant restrictions? “I think it’s a reasonable course of action and compromise. It will limit 99 percent of its use,” Nissen told the Wall Street Journal (subscription required).
A burden, all around. Charles Allen, CEO of national accounting firm Crowe Horwath, tells Becker’s Hospital Review about the effects of healthcare reform on five key groups.
When Investment Rhymes with Canada
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Staying in touch could lower costs. The systematic telephone outreach by trained nurses to patients at high risk of serious health problems may help solve rising healthcare costs, according to a New England Journal of Medicine article, reports The Fiscal Times.
Woman ‘cut in two.’ Rather than say goodbye to her toddler and newborn, Canadian Janis Ollson had the lower half of her body removed and then put back together at the Mayo Clinic in Rochester, Minnesota, to remove aggressive cancer, reports MSNBC/Today Show.
Lilly CEO wants more innovation. While praising some federal efforts to encourage regional innovation clusters such as Indiana’s life-sciences initiative, Eli Lilly and Co. Chief Executive Officer John Lechleiter pushed for additional steps, like tax changes, improving math and science education, and making it easier for companies to hire top scientists from other countries, according to the Indianapolis Star.
